Low incidence of asymptomatic contrast-enhancing brain lesions in Japanese patients with multiple sclerosis.
The number of contrast-enhancing brain lesions is used as an endpoint in multiple sclerosis (MS) clinical trials. However, the incidence of asymptomatic contrast-enhancing brain lesions (AEBLs) in Japanese patients with MS has not been determined. To describe the number of AEBLs per scan in Japanese patients with relapsing-remitting MS (RRMS). We reviewed the medical records of 23 Japanese patients with RRMS who showed (1) a stable or improving condition for at least 30 days before a magnetic resonance imaging (MRI) examination and (2) at least one relapse in the preceding year or two relapses in the preceding 2 years. The percentage of patients with AEBLs was 39.1% (9/23 patients) and the number of AEBLs per scan was 0.37. The results suggest that the disease activity shown by brain MRI was lower in Japanese patients with MS compared with that in Caucasian patients.